Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$98.98 - $115.74 $3.97 Million - $4.64 Million
-40,125 Reduced 0.76%
5,233,927 $606 Million
Q2 2023

Aug 14, 2023

BUY
$96.34 - $112.38 $14.7 Million - $17.1 Million
152,219 Added 2.97%
5,274,052 $542 Million
Q1 2023

May 15, 2023

SELL
$107.32 - $113.5 $18.7 Million - $19.8 Million
-174,485 Reduced 3.29%
5,121,833 $559 Million
Q4 2022

Feb 14, 2023

SELL
$62.39 - $113.8 $27.2 Million - $49.6 Million
-436,069 Reduced 7.61%
5,296,318 $603 Million
Q3 2022

Nov 15, 2022

BUY
$58.92 - $84.67 $11.1 Million - $16 Million
188,413 Added 3.4%
5,732,387 $355 Million
Q2 2022

Aug 15, 2022

BUY
$79.4 - $116.36 $5.2 Million - $7.62 Million
65,521 Added 1.2%
5,543,974 $442 Million
Q1 2022

May 16, 2022

BUY
$86.42 - $109.81 $358,210 - $455,162
4,145 Added 0.08%
5,478,453 $576 Million
Q4 2021

Feb 14, 2022

BUY
$98.56 - $119.91 $3.18 Million - $3.87 Million
32,291 Added 0.59%
5,474,308 $590 Million
Q3 2021

Nov 15, 2021

SELL
$91.91 - $110.37 $817,815 - $982,072
-8,898 Reduced 0.16%
5,442,017 $596 Million
Q2 2021

Aug 16, 2021

BUY
$86.24 - $95.92 $93.4 Million - $104 Million
1,083,282 Added 24.8%
5,450,915 $510 Million
Q1 2021

May 17, 2021

SELL
$71.83 - $95.48 $3.4 Million - $4.52 Million
-47,355 Reduced 1.07%
4,367,633 $402 Million
Q4 2020

Feb 16, 2021

BUY
$67.0 - $84.39 $128 Million - $162 Million
1,916,985 Added 76.74%
4,414,988 $323 Million
Q3 2020

Nov 10, 2020

SELL
$55.23 - $79.93 $1.6 Million - $2.32 Million
-28,984 Reduced 1.15%
2,498,003 $194 Million
Q2 2020

Aug 14, 2020

SELL
$30.2 - $56.98 $4.16 Million - $7.85 Million
-137,850 Reduced 5.17%
2,526,987 $140 Million
Q1 2020

May 11, 2020

BUY
$24.87 - $38.56 $66.3 Million - $103 Million
2,664,837 New
2,664,837 $78.9 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.